GlassScriptPhysician profile
Phillip Rhys Say
NPI 1972591899
$2,434.27
in general payments reported to CMS, 2019-2025
12 companies · $918 in 2025
The $918 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.94 · 2020: $124 · 2021: $245 · 2022: $251 · 2023: $356 · 2024: $486 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.87 |
| Education | $155.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $836.79 | 2023-2025 | Dupixent, Libtayo |
| Optinose US, INC. | $656.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $316.13 | 2022-2025 | Nucala |
| Genzyme Corporation | $262.75 | 2023-2025 | |
| Stryker Corporation | $127.51 | 2023-2025 | Xpress Loprofile, Scopis Ent, Clarifix |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Medtronic, INC. | $39.96 | 2023-2024 | Signia, Nuvent |
| Hologic Sales and Service, LLC | $21.34 | 2023 | Coolseal Generator |
| Itamar Medical INC | $20.19 | 2023 | Watchpatone |
| Amgen INC. | $19.56 | 2025 | Tezspire |
| Intersect Ent, INC. | $19.00 | 2019 | |
| Ethicon US, LLC | $15.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Say listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.